Keywords: Prostate, Prostate, Cancer, Hyperpolarized MR
Motivation: Monitoring the progression or response of advanced prostate metastases is a current clinical unmet need that is not reliably delineated with current CT and PET.
Goal(s): Here, we developed a high-resolution whole abdominopelvic [1-13C]pyruvate HP MRI approach for the metabolic biomarker characterization of metastases in prostate cancer patients.
Approach: A variable-resolution imaging approach was used to provide high-resolution [1-13C]pyruvate, robust spatiotemporal denoising and B1+ variation correction methods were used to quantify the rate-constant for the conversion of [1-13C]pyruvate to lactate, kPL.
Results: Improved conspicuity of [1-13C]pyruvate distribution and kPL conversion maps of metastatic lesions were achieved with the new approach.
Impact: The improvement in [1-13C]pyruvate resolution and clear delineation of highly metabolically active metastatic lesions in kPL maps demonstrated the potential of [1-13C]pyruvate HP MRI in advanced prostate cancer.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords